Drug recall · November 29, 2023
Tiglutik recall
Why: Failed Viscosity Specifications: Out-of-specification test results for viscosity
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Tiglutik (riluzole) Oral Suspension 50 mg/10 mL (5 mg/mL), 600 mL (two bottles/300 mL each), RX only, Manufactured for ITF Pharma, Inc., Berwyn, PA 19312 USA NDC:70726-0303-1 (carton) and 70726-0303-2 (bottle)
- Lots / codes
LOT# 2231901, Exp. 11/30/2025; 2307901, Exp. 03/31/2026
- Quantity
- 1,792 bottles
- Company
- Itf Pharma Inc, Berwyn, PA
- Distribution
- Distributed to one distributor in TN who may have further distributed.
- Initiated
- October 20, 2023 · Voluntary: Firm initiated
- Classified
- November 21, 2023
- Reported
- November 29, 2023
- Ended
- January 28, 2025
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Riluzole
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.